Company Performance: ADC Therapeutics' financial health, including revenue growth, profitability, and cash flow, strongly influences its stock price.

Clinical Trial Results: Positive or negative data from clinical trials for ADC Therapeutics' cancer therapies significantly impacts investor sentiment and the stock's value.

Regulatory Approvals: FDA or other regulatory agency approvals for ADC Therapeutics' drugs are major catalysts that can drive the stock price higher.

Market Sentiment: Overall investor mood towards the biotech sector and the broader stock market affects ADC Therapeutics' stock price.

Competition: The presence and performance of competing cancer therapies can influence the demand and perceived value of ADC Therapeutics' products.

Partnerships and Acquisitions: Strategic alliances, collaborations, or potential acquisitions can create value and affect the stock price.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth can indirectly affect investment decisions and the stock market.

Analyst Ratings: Recommendations from financial analysts can sway investor opinion and impact trading activity.

News and Events: Company-specific news, industry developments, and major global events can cause fluctuations in the stock price.